Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.42 Up 0.04(9.32%) Aug 31, 3:59PM EDT
Add to Portfolio
Prev Close:0.38
Open:0.42
Bid:0.39 x 2000
Ask:0.55 x 200
1y Target Est:5.00
Beta:2.61727
Earnings Date:Nov 4 - Nov 9 (Est.)
Day's Range:0.39 - 0.43
52wk Range:0.30 - 1.47
Volume:792,326
Avg Vol (3m):795,372
Market Cap:22.18M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXAUp 9.32%22.18M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Sep-15) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback